Literature DB >> 18191574

Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment.

Tuğba Tunç1, Leyla Cavdar, Yeşim Sücüllü Karadağ, Esra Okuyucu, Ozlem Coşkun, Levent E Inan.   

Abstract

This study was performed to investigate the differences in response to botulinum toxin treatment between patients with idiopathic versus neurovascular hemifacial spasm. A total of 69 patients with hemifacial spasm were investigated prospectively with cranial magnetic resonance imaging and magnetic resonance angiography. Neurovascular contact was found in 23 patients. All patients were assessed with a severity scale and a disease awareness scale. After treatment, the patients with idiopathic hemifacial spasm improved significantly in terms of both severity and awareness scores, but the patients with neurovascular hemifacial spasm improved only in the awareness scores. In conclusion, patients with idiopathic hemifacial spasm experienced a greater improvement after treatment with botulinum toxin than did patients with neurovascular hemifacial spasm.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191574     DOI: 10.1016/j.jocn.2007.02.002

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Validation of the Hemifacial Spasm Grading Scale: a clinical tool for hemifacial spasm.

Authors:  Nicola Tambasco; Simone Simoni; Elisa Sacchini; Paolo Eusebi; Erica Marsili; Pasquale Nigro; Elona Brahimi; Federico Paolini Paoletti; Michele Romoli; Paolo Calabresi
Journal:  Neurol Sci       Date:  2019-05-10       Impact factor: 3.307

Review 2.  Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment.

Authors:  Bettina Wabbels; Peter Roggenkämper
Journal:  J Neural Transm (Vienna)       Date:  2012-01-10       Impact factor: 3.575

3.  Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters.

Authors:  Bettina Wabbels; Ali Yaqubi
Journal:  J Neural Transm (Vienna)       Date:  2021-05-08       Impact factor: 3.575

Review 4.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

Review 5.  Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.

Authors:  Nicola Tambasco; Marta Filidei; Pasquale Nigro; Lucilla Parnetti; Simone Simoni
Journal:  Toxins (Basel)       Date:  2021-12-09       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.